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Little is known about the mechanisms of host
resistance to candidal infections. Attempts to
correlate specific circulating antibodies and
skin test reactions with clinical disease have
resulted in conflicting data. The effect of
serum on the growth of Candida olbicans has
been studied in several in vitro systems. In
1959, Roth and coworkers described an in-
hibitory factor in normal adult serum and
demonstrated its absence in newborns and in
infants up to 6 weeks of age (1). Subsequently,
markedly decreased levels of inhibition were
demonstrated in the sera of several patients
with acute leukemia, Hodgkin's disease and
multiple myeloma; normal levels were found
in individuals with chronic leukemia, dia-
betes and earcinomatosis (2). Louria de-
scribed a serum factor lethal for Candida
albicans which appeared to differ from Roth's
factor in respect to specificity and apparent
physical characteristics (3). Differences in
methodology preclude direct comparison. Both
of these factors appeared to be distinct from
classical serum antibody.
Another effect of human serum on Candida
albicams is the rapid formation of germ tubes
at 37° C. (4—8). Whether this form of Candida
represents inhibited or enhanced growth is at
present unresolved. Germ tube formation, how-
ever, has been linked with the transferrin-iron
complex and this property may represent a
mechanism of host defense (9).
It is not known whether these serum factors
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are in fact manifestations of the same biologic
phenomenon in different in vitro systems, nor
has their relation to candidal infection been
established. In the present study an attempt
was made to reproduce Roth's system and to
further characterize this particular inhibitory
factor.
MATERIALS AND METHODS
Yeast strain—A single strain of Candida albi-
eons was used throughout the study. It was isolated
from a patient with vaginitis and identified as C.
albicons by production of ch]amydospores on corn
meal agar, formation of germ tubes on incubation
for 2 hours in serum at 37° C., and by pigment
production on Nickerson's medium. The strain
was maintained on Saboraud's medium and sub-
cultured monthly.
Inoculum.—Suspensions of yeast cells were made
from a standardized loopful of C. albicans inocu-
lated into 25 ml. of a dextrose-peptone-ycast
extract broth (5% peptone, 02% dextrose, 0.1%
yeast extract, 0.3% NaC1; pH 6.6) in a 250 ml.
Erlcnmeycr flask. The flasks were placed on a
gyrotary shaker and agitated at 200 r.p.m. for
20 hours at room temperature. Preliminary growth
curves in this medium indicated that the cell
population (by hemocytomcter chamber counts),
optical density (O.D.) and transmission (%T) at
650M were consistently correlated. Call growth
leveled off by 20 hours of incubation; cultures
were harvested at this time to avoid significant
numbers of nonviable cells in the inoculum. The
harvested cultures were packed by low speed
ccntrifugation and washed X2 with 25 ml. of
sterile, physiologic saline at 40 C. They ware
resuspended in 25 ml. of sterile normal saline and
aliquots counted in a standard hemocytometer
chamber. Final inocula of 250,000—350,000 yeast
cells/ml. ware made by dilution with cold physio-
logical saline containing 0.2% dextrose. One-tenth
ml. of the inoculum was used in each assay tube.
This inoculum size (without serum) resulted in a
turbidity which allowed only 25—30% transmission
at 6SOq after 24 hours. Smaller inocula produced
insufficient turbidity in the control tube to allow
meaningful comparison with the assay tubes;
larger inocula (7—lox) resulted in too great an
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increase in turbidity in the assay tubes to provide
clearcut separation of normally and abnormally
inhibiting sera as compared to the control.
Glosswczre.—Glassware was made iron-free by
soaking for 24 hours in a 1: 1 solution of concen-
trated 11N03 (40% Technical) and demineralized
water followed by rinsing X6 in demineralized
water. It was sterilized by autoclaving for 20
minutes. Quantitative iron assay demonstrated
complete removal of iron by this procedure (10).
Sera.—Serum was collected aseptically with
plastic syringes and disposable i 10 gauge needles
in iron-free tubes. After clot retraction the samples
were centrifuged and stored in iron-free vials at
—20° for periods up to 6 months. No loss of
inhibitory activity was detected after storage for
this period. No change in the inhibitory capacity
of several sera was demonstrated after multiple
freezing and thawing (X5). Repetitive experiments
with a single serum could be reproduced with a
precision of 5% and usually in the range of 3%.
Assay—The assays were performed in sterile,
iron-free, 10 >< 75 mm. O.D. Coleman tubes
covered with aluminum foil. The final volume was
2 ml. and contained 0.4 ml. of serum, 1 ml. of
broth, 0.1 ml. of the C. albicans suspension
(250,000—350,000 cells/ml.), and 0.5 ml. of physio-
logic saline containing 02% dextrose. Controls
in each assay included a tube without serum, a
blank of broth and dextrose-saline, and a tube
with a stock serum pooled from four individuals
with normal inhibitory activity. The initial per-
cent transmission and O.D. were read at 6SOc on
a Coleman Jr. Spectrophotometer, Model 6A. The
suspension was then transferred via sterile acid-
washed disposable pipettes to 25 X 105 mm. Cole-
man tubes since agitation in the smaller tubes
was insufficient to prevent macroscopic clumping
of the cells. The tubes were placed in racks on a
gyrotary shaker at 160 r.p.m. for 24 hours at room
temperature. At the end of this period the material
was re-transferred to 10 X 75 mm. Coleman tubes
for O.D. readings. Optical density between 0.20
and 0.40 was linearly related to the log10 of cell
numbers. The 24 hour time period was chosen
because timed experiments indicated that suffi-
cient growth had occurred in the control tubes at
this interval. Smears for microscopic examination
were prepared from each tube to assure the
absence of bacterial or fungal contamination.
RESULTS
The assay results of sera from one hundred
and twenty-two patients are shown in Fig-
ure 1. The data are presented in terms of
change in transmission of light at 6SOto (AT
Ftc. 1. Inhibitory activity of 122 sera expressed
as the change in percent transmission (AT) after
24 hours of incubation with C. olbicans.
= initial % transmission — % transmission
at 24 hours). A large AT would therefore in-
dicate maximal eandidal growth, hence lack
of inhibition. A small AT conversely signified
little growth, hence significant inhibition.
Sixty-six sera were from children, aged three
months to 15 years, who were seen for super-
ficial bacterial pyoderma. Fifty-six of these 66
individuals had a AT of 15 or below (small
change in transmission = little growth =
normal inhibition). Only three sera showed
a AT greater than 30. The sera from five pa-
tients under three months of age showed a
marked decrease in serum inhibitory activ-
ity, and are grouped separately in Figure 1.
The AT ranged from 46 to 79, and within this
group of five infants was not correlated with
age.
Fourteen paired maternal and cord sera were
obtained at the time of delivery. All of the
maternal sera demonstrated normal inhibition
(0—23 AT). In contrast, no inhibitory activity
was seen in any of the cord samples (67—77
AT). Maternal serum from one pair was un-
available for study.
Twenty-four patients with hemoglobinop-
athies included 12 with 55 hemoglobin,
three with SC hemoglobin, six with SA, and
three with AC hemoglobin. All of the SS sera
were lacking in inhibitory factor though one
of the twelve approached normal levels. The
AT for the SS sera ranged from 56—75 with
one specimen having a AT of 33. Sera from
the other three hemoglobin types were all
normal in their inhibitory response except
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1. Candidiasis; idiopathic
hypoparathyroidism
2. Candidiasis; Addison's
disease
3. Candidiasis; Addison's
disease
4. Candidiasis; idiopathic
hypoparathyroidism
5. Candidiasis; idiopathic
hypoparathyroidism
6. Candidiasis
7. Candidiasis
8. Candidiasis; idiopathic
hypoparathyroidism
9. Candidiasis; idiopathic
hypoparathyroidism
10. Candidiasis; idiopathic
hypoparathyroidism
11. Candidiasis; idiopathic
hypoparatbyroidism
12. Candidiasis; idiopathic
hypoparathyroidism
13. Candidiasis; idiopathic
hypoparathyroidism
14. Candidiasis
15. Candidiasis; idiopathic
hypoparathyroidism
16. Candidiasis; Addison's
disease
17. Candidiasis; idiopathic
hypoparathyroidism
18. Candidiasis; idiopathic
hypoparathyroidism
19. Candidiasis
20. Candidiasis
21. Candidiasis; idiopathic
hypoparathyroidism
22. Candidiasis; idiopathic
hypoparathyroidism
23. Candidiasis; idiopathic
hypoparathyroidism
24. Candidiasis; idiopathic
hypoparathyroidism;
Addison's disease
Diagnosis AT
Chronic acidosis 67
Congenital hereditary sphcrocytosis 63
Hypoplastic anemia 74
Aplastic anemia; subcutaneous can- 49
didal granulomas
Acute leukemia 75
Lymphoma 28
hodgkin's disease; C. albicans grown 5
from multiple bronchoscopy cul-
tures
Chronic candidiasis, lips 4
Chronic candidiasis, CI 2
Chronic candidiasis, diaper area 5
Diabetes 6
Diabetes 2
Diabetes 2
in combination with idiopathic hypopara-
6 thyroidism and/or Addison's disease. Involve-
17 ment with C. albicams was limited to the skin
19 and mucous membranes in all cases. While five
of these individuals had candidiasis only, they
10 were referred to an endocrine clinic because
8 of persistent infection and suspected cndo-
crinopathy. The data are listed in Table I.
Within the group are three sibling pairs (7
and 8, 15 and 16, 11 and 24). Eighteen of these
1 patients had normal inhibitory capacity (T
1—26); serum from the remaining six had de-
7 creased ability to inhibit candidal growth (T
44—61). There was no correlation of lack of in-
6 hibition with age or diagnosis.
A small series of patients, all over age three
8 years, with blood dyscrasias, diabetes or
chronic candidiasis was also studied, and the
results are listed in Table II. Those individuals
with hematologic abnormalities (anemia or acute
26 leukemia) exhibited poor inhibition. Those with
chronic cutaneous candidiasis or diabetes (in-
52 eluding two hyperglycemic scra) inhibited nor-
44 mally.
54
COMMENT
It is apparent from the results of the present
61 study, confirming those of Roth and Gold-
stein (2), that normal human serum possesses
the capacity to inhibit in vitro growth of C.
albicans at 25° C. The demonstration of this
phenomenon is entirely dependent upon several
for one SC and one AC. The six SA sera
ranged from 1—23 LiT. The SC values were
LiT 8, 9, and 68; the AC values were 1, 3,
and 44 LiT.
Sera were obtained from 24 patients, ages
3—61 years, seen in the pediatric endocrine
clinic with a diagnosis of candidiasis alone or
TABLE I
TABLE II
Diagnosis Age AT
7
8
3
11
S
24 yrs.
61 yrs.
12 yrs.
19 yrs.
15 yrs.
7 yrs.
22 yrs.
12 yrs.
16 yrs.
12 yrs.
10 yrs.
15 yrs.
4 yrs.
3 yrs.
16 yrs.
19 yrs.
7 yrs.
15 yrs.
child
20 yrs.
8 yrs.
3 yrs.
20 yrs.
12 yrs.
46
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factors including inoculum size, concentration
of serum, duration of assay, avoidance of con-
tamination, and prevention of large aggregates
of cells. In addition temperature is a critical
factor since germ tube formation occurs with
incubation at 37° C. In this specific system
the degree of inhibition for the normal popu-
lation is somewhat variable but usually falls
below a of 30. No explanation is apparent
for the failure of serum from three normal in-
dividuals to inhibit candidal growth. Addi-
tional sera were not available and follow-up
information could not be obtained. Prior his-
tory, however, excluded hemoglobinopathy and
blood dyserasia.
The striking absence of inhibitory capacity
in neonatal sera is of interest in view of the
susceptibility of this age group to Candida
albicans infection. Furthermore, this anti-
candidal factor can first be demonstrated at
the time when two important biologic sys-
tems are also changing. Although the factor is
probably unrelated to known antibody systems,
gamma-globulin markedly increases during
this period. More pertinent perhaps is the
concomitant onset of a physiologic iron de-
ficiency anemia.
While it is tempting to speculate that the
high incidence of candidal infection in the
neonatal period is wholly or in part attribut-
able to absence of an inhibitory factor, the
data in this and Roth's study (2) show a
poor correlation with clinical infection. In
addition, the low levels of factor in patients
with sickle cell disease do not support such a
correlation. The susceptibility of patients
with sickle cell anemia to certain bacterial in-
fections is well known, but there is no evidence
of an increased incidence of mucocutaneous
eandidiasis in these individuals. There is, how-
ever, a single report of a patient with SC disease
and eandidal esophagitis (11). This is of interest
in that systemic involvement with C. albicans
occurs rarely in the absence of debilitating dis-
ease or prolonged courses of eortieosteroids or
broad-spectrum antibiotics. Normal inhibitory
capacity was present in the susceptible diabetics
and clinically infected individuals. Further evi-
dence for a poor correlation with clinical disease
was demonstrated by the results obtained with
sera from patients with candidiasis and endo-
erinopathies. Although six sera had a reduced
inhibitory capacity, insufficient serum precluded
further study of these individuals.
The low level of inhibition seen with SS
serum and the normal levels demonstrated in
patients with sickle trait correlate inversely
with the degree of anemia present in the two
groups. The importance of this relationship is
further suggested by the limited data from
isolated cases of congenital hereditary sphero-
cytosis, hypoplastie and aplastie anemia, and
may also be the explanation for the absence
of inhibition noted in some patients with
leukemia.
It has been demonstrated by Landau et al.
(9) that the serum germ tube factor is related
to levels of transferrin and iron. This prop-
erty, the stimulation of germ tube production
by Candida albicans at 37° C., is greatly en-
hanced by the addition of ferrous ammonium
sulfate sufficient to saturate the endogenous
transferrin. It is postulated that the increase in
germ tube formation in the presence of serum
with saturated transferrin is due to the re-
moval of an inhibitory effect of unsaturated
transferrin rather than to an increase in avail-
able iron. However, the work of Caroline et al.
(12) has been interpreted as indicating that the
degree of inhibitory capacity of serum at 37° C.
is related to the binding of iron by unsaturated
transferrin. This iron then would not be
available for candidal growth.
It is probable that the several described
factors are interrelated and may well represent
the same inhibitory effect in different in vitro
systems. Demonstration of a relation between
inhibitory activity and the degree of unsatura-
tion of transferrin in the present system would
help to clarify this point. Investigation of the
iron binding capacity and serum iron of both
inhibiting and non-inhibiting sera is in progress
and will be reported subsequently. Certainly
the absence of inhibitory factor in infants, whose
transferrin is highly saturated, and in patients
with anemias are suggestive of dependence on
the iron-transferrin complex.
SUMMARY
1. The ability of sera from normal children
to inhibit multiplication of Candida albicans
in vitro was confirmed.
2. Assay of paired maternal and cord sera
showed a normal inhibitory capacity of ma-
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ternal serum and marked diminution in in-
hibitory capacity of cord serum.
3. Sera from five infants under three months
did not inhibit eandidal growth.
4. Inhibitory capacity was markedly re-
duced in serum from patients with sickle cell
disease whereas sickle trait (heterozygote)
serum inhibited normally. Hemoglobin C
trait and SC individuals probably also have
a normal capacity to inhibit in vitro repro-
duction of C. albiean,s.
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